Dr. Jerry Silver Research Fans

NervGen Wings for Life Go NIKO! 💪
https://www.wingsforlife.com/uk/latest/nvg-291-a-new-hope

Larry Williams details how NVG-291 changed his life and details his recovery!
See: https://www.cbsnews.com/philadelphia/video/how-an-experimental-drug-is-helping-this-pennsylvania-man-recover-from-an-accident/?

📣📣📣 MORE BREAKING NEWS from NervGen Pharma!
See: https://www.stocktitan.net/news/NGENF/nerv-gen-pharma-s-nvg-291-r-demonstrates-significant-functional-11t8n2nkjtd3.html

NVG-291 Inventor Dr. Brad Lang is interviewed on Blink of an Eye SCI Podcast!

🚨𝗡𝗘𝗪 𝗘𝗣𝗜𝗦𝗢𝗗𝗘🚨 𝗦𝗲𝗮𝘀𝗼𝗻 𝟱, 𝗘𝗽𝗶𝘀𝗼𝗱𝗲 𝟱𝟳: Understanding the Chemistry of NVG-291’s Efficacy for Rewiring SCI Recovery with Dr. Brad Lang Biotech inventor Dr. Brad Lang shares the story of discovering ISP—the science behind NVG-291 trials showing new hope for spinal cord injury recovery. From lab research to clinical trials, hear how persistence, science, and hope are reshaping what’s possible. 🎧 Listen now! #SCIRecovery #Neuroscience #MedicalInnovation #NVG291 #HopeAfterSCI

NeurologyLive spotlights results from NervGen Pharma Corp’s chronic clinical
trial at Shirley Ryan AbilityLab!

Insights on NervGen Pharma’s Positive Phase 1b/2a Data for NVG-291 in Spinal Cord Injury Daniel Mikol, MD, PhD, chief medical officer at NervGen Pharma, provided clinical perspective on recently announced positive findings from a phase 1b/2a trial testing NVG-291 as a treatment for spinal cord injury.

Are you just now learning about the pioneering research of Dr. Jerry Silver, which led to the development of NVG-291 by NervGen Pharma Corp?
Here’s a video showing robust recovery in animal tests.

Rats before and after NVG-291, Nervgen Material is copied from Nervgen's origin story video. I edited it by slowing down the rats to .65 speed so we can see the rat limb movement more clearly. I...

NervGen Pharma Corp is currently conducting a clinical research trial of subacute (recent) patients with a spinal cord injury.
Dr. Jerry Silver is the medical researcher whose work led to the development of NervGen’s peptide treatment, NVG-291.
In animal studies, animals regained their bowel and bladder function with a high dose of the medication.https://nervgen.com/wp-content/uploads/2023/02/NervGen-Corporate-Presentation_Feb-14-2023_Web.pdf

Great info from the Shirley Ryan AbilityLab!

After a spinal cord injury (SCI), patients and their families often face a flood of unfamiliar medical terms.

As we recognize Disability Pride Month, we’re sharing our guide to common terms about SCI — designed to make it easier to understand complex terminology so that patients can take an active role in their rehabilitation and healing.

Read the full article to learn more: bit.ly/3GzgdL6

Check out this NVG-291 research presentation by NervGen Pharma Corp CEO Mike Kelly!
Watch: https://youtu.be/rHmdNukP3UA

Check out this interesting interview with NervGen Pharma Corp CEO Mike Kelly! He explains how NVG-291 works and how he met the late Dr. Jerry Silver.
“Spinal cord injuries (SCI) can be devastating. Victims can often be left with permanent disabilities and debilitating pain.
Mike Kelly, president and CEO of NervGen, spoke with Pharmaceutical Executive about the company’s unique approach to actually repairing these injuries. The company’s primary drug, NVG-291, has shown the ability to activate the body’s ability to heal itself…”
See:
https://www.pharmexec.com/view/repairing-spine-mike-kelly-ceo-nervgen

Check out this article about the late Dr. Jerry Silver and his research which led to NVG-291!

NervGen’s NVG-291 brings New Hope for People With Spinal Cord Injuries | News | Spinal Cord Injury Zone! (NAPSI)—If you or someone you care about is ever among the approximately 17,700 Americans who each year, according to The Journal of American Medical